FIGURE 3. Bioconjugate stability in the presence of serum.
NMEGylated therapeutics were incubated in human plasma at 37 °C and sampled at certain time points, followed by RP-HPLC analysis. The amount of remaining peptide or peptide-peptoid conjugate at each time point was quantified against an enzyme-stable internal organic standard (benzyl alcohol).